...
首页> 外文期刊>Athletic therapy today : >Evidence-Based Guidelines for Utilization of Dexamethasone Iontophoresis
【24h】

Evidence-Based Guidelines for Utilization of Dexamethasone Iontophoresis

机译:地塞米松离子电渗疗法的循证指南

获取原文
获取原文并翻译 | 示例
           

摘要

Iontophoresis involves transmission of ionized medicated and non-medicated substances into the skin. An electrical field is produced between two electrodes that have opposite polarities, which either repel or attract ions within a medication. The basic principle underlying iontophoresis is that opposite charges attract each other and like charges repel each other. Thus, medications with a positive charge will be repelled by an electrode with positive polarity (anode), and those with a negative charge will be repelled by an electrode with negative polarity (cathode). Lachaud studied the use of corticoste-roids in iontophoresis, which led to the use of dexamethasone as the primary anti-inflammatory medication administered through iontophoresis treatments. Common medications used to treat orthopedic conditions through iontophoresis include dexamethasone, acetate, hydrocortisone, and lidocaine.
机译:离子电渗疗法涉及将离子化的药物和非药物物质传输到皮肤中。在具有相反极性的两个电极之间会产生电场,该电场会排斥或吸引药物中的离子。离子电渗疗法的基本原理是相反的电荷相互吸引,而类似的电荷则相互排斥。因此,带正电荷的药物将被正极性的电极(阳极)排斥,而带负电荷的药物将被负极性的电极(阴极)排斥。 Lachaud研究了皮质类固醇在离子电渗疗法中的使用,从而导致地塞米松作为通过离子电渗疗法治疗的主要抗炎药。通过离子电渗疗法治疗骨科疾病的常用药物包括地塞米松,醋酸盐,氢化可的松和利多卡因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号